HCPLive

Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 

Most Popular

Recommended Reading

Fred Lublin, MD, and Patricia K. Coyle, MD, discuss key issues regarding family planning, pregnancy, and disease-modifying therapies in patients with multiple sclerosis.
Fred Lublin, MD, and Patricia K. Coyle, MD, describe the dangers of smoking related to MS.
The field of medical technology is constantly expanding and changing requiring new equipment to be used in a variety of ways. That effort has been brought under one roof at Massachusetts General Hospital thanks in part to the efforts of one generous and appreciative patient.
A cardiovascular disease risk equation has been developed that can be recalibrated for application in different countries, according to a report published online March 25 in The Lancet Diabetes & Endocrinology.

$vAR$